Category Archives: Stocks to Watch

Global Payout, Inc. (GOHE) is Making Worldwide Financial Transactions Seamless

July 24, 2017
  • Connecting a global financial market to a private banking network
  • A cloud-based financial platform for trading & settlement of depositary accounts
  • Using blockchain technology to deliver secure financial transactions

Banking has come a long way from the time when moneychangers set up their tables in the marketplace. The technology then was minimal: paper records of bills of exchange and letters of credit. Today, technology dominates banking. More than a quarter (about 9,000) of Goldman Sachs’ 33,000 full-time employees are engineers and programmers, by one account (http://dtn.fm/dX51Z). Its CEO is on record as saying that Goldman Sachs (NYSE: GS) is a technology firm, a pointed indication of the extent to which information technologies have permeated modern banking. To serve this growing fintech market, California-based Global Payout, Inc. (OTC: GOHE) is rapidly developing a variety of innovative products. The company is offering state-of-the-art software solutions to fintech companies involved in processing money remittances, wire transfers, bill payments, business-to-business (B2B) payments, currency exchange, eWallet payments and other types of financial transactions.

Since its inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. The company was founded by Jim Hancock, who has guided its evolution from a program management and consulting services company offering prepaid debit cards and electronic wallet products to the global, full-service payment platform it is today. Hancock is Global Payout’s current CEO and chairman. His 30 years of experience range over a variety of industries and include senior positions in investment banking, mergers and acquisitions, payment processing and telecommunications. For the last 14 years, he has successfully managed close to 40 custom-designed prepaid debit card programs. Hancock intends to leverage his vast array of contacts and in-depth knowledge of the payment industry in executing Global Payout’s new initiatives.

These began in 2014, when the company introduced its first online payment platform, called the Consolidated Payment Gateway (CPG). CPG allows its enterprise clients the capability to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of the company’s present, state-of-the-art fintech payment system in 2016, which both expands the range of financial services available to clients and offers them reduced transaction costs.

In January 2017, Global Payout announced a licensing agreement with First American Electronic Payment Solutions, Inc., producer of an innovative software system for companies wishing to process money remittances, wire transfers, bill payments, B2B transactions, eWallet payments and transfers, currency exchanges and other types of financial transactions. This collaboration provides the backbone infrastructure that supports the company’s recently introduced Global Reserve Platform (GRP), a customizable, “banking-in-a-box” web-based platform. GRP offers the capability to execute the front-to-back office processing requirements of domestic/foreign exchange and international payment service providers and is expected to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

Global Payout is connecting this worldwide cloud-based financial services platform to traditional banking. The company holds majority control of ISBC Holdings, Ltd., the sole domestic and international management company for the International Sovereign Banking Corporation (ISBC). ISBC is a privately-owned sovereign nation bank to be held on the sovereign tribal land of the Wakpamni Lake Community, Oglala Sioux Tribe located at the Pine Ridge Tribal Reservation in South Dakota.

With such a spectrum of services, Global Payout can offer traditional banking and products to businesses that cannot access those services. For example, last year, the company announced that Marijuana Company of America (OTC: MCOA) had selected Global Payout as its financial solutions provider (http://dtn.fm/bM1ZE). Global Payout’s CPG and MoneyTrac prepaid solutions will enable MCOA to process membership fees and pay vendors, employees, and affiliates. MCOA members will be able to make purchases using an MCOA-branded prepaid card, reducing cash transactions and enabling online and mobile purchases. This significantly reduces the risk associated with operating a cash-only cannabis business and the legal perils associated with the substance.

For more information, visit the company’s website at www.GlobalPayout.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

MoneyOnMobile (MOMT) Digital Mobile Payment Network Services World’s Largest Under-Banked Population

  • India has world’s second-largest population at 1.35 billion
  • India is largest under-banked population in the world
  • MoneyOnMobile services under-banked with digital mobile payment network
  • 39 percent monthly compounded revenue growth in Q1

With an average growth rate of around seven percent over the last two decades, India’s economy is the sixth-largest in the world measured by GDP and the third-largest by purchasing power. In spite of its economic prowess, the Indian consumer market is the largest under-banked population in the world. Banking services are scarce and woefully inadequate, forcing cash transactions and chocking consumer purchasing power. A prime example of scarce banking services is India’s paltry 200,000 ATMs servicing its 1.35 billion citizens. India would need two million more ATMs in order to have the same ratio of ATMs to people as in the U.S.

Since 2010, MoneyOnMobile, Inc. (OTCQX: MOMT) has been delivering needed services to India’s vast un-banked and under-banked population. MoneyOnMobile is a digital mobile phone payment network that allows consumers to deposit cash with one of its 335,000 retailers in 700+ cities. MoneyOnMobile is authorized by the Reserve Bank of India (RBI) to set up this semi-closed payment network, which enables registered users to buy goods, products and services from registered merchants.

The consumers’ cash deposits become digital currency in MoneyOnMobile’s computerized records. Consumers then have the ability to perform over 55 different transactions, including various bill payments, cash withdrawal, domestic remittances and money transfer using only their mobile phone and SMS text messaging. The system is faster, safer, more reliable, cheaper and much easier to use than transacting in all cash.

MoneyOnMobile is being embraced by the Indian un-banked and under-banked consumer, and the company’s reach into the remotest parts of India makes it the go-to prepaid instrument on the market today. The company has already served over 198 million cumulative unique mobile phone number users and has processed $1.8 billion worth of transactions. Convinced it’s just getting traction, MoneyOnMobile had 39 percent monthly compounded revenue growth in the three months from January to May 2017.

MoneyOnMobile’s cellular prepaid digital payment system is directly centered in one of highest spheres of growth in the financial services arena. The company’s no-cost to end-user services meet a vast unmet need in one of the world’s most populated countries, providing users newfound flexibility and self-dependence. It shouldn’t be long before MoneyOnMobile’s growth numbers eclipse the first three months of this year.

For more information, visit the company’s website at www.Investors.MoneyOnMobile.in

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Invictus MD (TSX.V: IMH) (OTC: IVITF) Poised to Have First-Mover Advantage in Canada’s Legal Cannabis Market

July 6, 2017
  • One of few Canadian cannabis companies to declare dividends
  • Poised for first-mover advantage in Canada’s legal marijuana market
  • 250 acres of cultivation space spanning from Alberta to Ontario

Retail sales in Canada’s recreational marijuana market could climb to $6.0 billion by 2021, according to Deloitte Canadian, and Invictus MD Strategies Corp. (TSX.V: IMH) (OTC: IVITF) is strategically positioned to grow right alongside this burgeoning market and gain first-mover advantage as soon as Canada’s cannabis market is freed up by the necessary legislative regulations.

Founded in Vancouver, Canada, Invictus MD is a cannabis company that is dedicated to offering high-quality, regulated pharma-grade marijuana for both medical and recreational use using clean and organic production practices. The company represents a platform of licensed cannabis producers located throughout Canada who operate under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company’s growers are supported by more than 250 acres of production capacity and have total access to Invictus MD’s team of leading horticulturists, biochemists and project managers.

Since its inception, Invictus MD has had its developmental focus on a future time when the marijuana industry will be fully opened into a regulated consumer market. Boosted by legislative progress in Canada, the company has quickly established one of the strongest cultivation profiles in that country, with fully expandable facilities that allow its licensed producers to meet the growing demand for medical cannabis and, soon, for recreational marijuana, as well.

Invictus MD intends to constantly innovate its cultivation process and deploy long-term expansion plans to strengthen its production capacity. In carrying out its strategy for market domination, Invictus MD has completed various shrewd acquisitions that have resulted in huge ROIs (http://dtn.fm/z3Ac6). In all thus far, the company has expended $1.1 million in acquisitions and has gained over $4.1 million in disposals.

Invictus MD stands out among very few Canadian cannabis companies that have declared dividends and is well-positioned to become a leader in the legal cannabis space – not just in Canada but globally.

For more information, visit the company’s website at www.Invictus-MD.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is a Technology Disruptor for Edible Cannabinoids

July 5, 2017
  • First mover in plant-to-bloodstream niche
  • Proprietary technology improving bioavailability of orally ingested cannabinoids
  • Two distinct consumer product brands: ViPova and Lexaria Energy

With the recreational market set for legalization on July 1, 2018, Canada’s cannabis industry is experiencing a high that is catalyzing innovation in the biosciences sector. Pioneering biopharmaceutical companies there and in other developed countries are working to develop a variety of healthful products based on their research into cannabinoids. As a result, investment capital flow to “plant-to-bloodstream” companies is expected to swell just as it has been doing for “seed-to-plant” companies for some time, and innovative British Columbia-based outfit Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) will, undoubtedly, be buoyed by this development, since it is a “first mover” in this space.

Lexaria is one of that new breed of “plant-to-bloodstream” companies exploring ways to make the health benefits of cannabinoids more accessible. The company has developed technology that delivers the nutriments of hemp oil in a novel and more effective way. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.

In general, the human gastrointestinal tract does not handle cannabinoids effectively, and much of what is ingested is simply excreted by the body. In addition, realizing this, many users of edible products will try other cannabinoid delivery methods, such as smoking, with their attendant evils. For those smoking cannabis, there is more peril in the smoking than in the cannabis.

Lexaria applies its innovative delivery technology to its product line, which consists of two distinct brands: ViPova™ and Lexaria Energy. ViPova™ is a delicious Chinese black tea from the province of Yunnan, made from hemp oil-infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a host of varieties and flavors. The ViPova range runs from 8- to 32-bag portions, and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.

If you are a couch potato, Lexaria Energy products are not for you. The Lexaria Energy line is meant for those with busy, active lifestyles. Under this brand, the company has launched a hemp oil-infused protein bar called the Lexaria Energy Bar, which, as its name suggests, provides reserves of energy you can draw on to go the extra mile.

Lexaria is not resting on its laurels with these groundbreaking developments. In February 2017, it signed a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions. Lexaria believes its patented technology can be applied to the delivery of nicotine, vitamins, analgesics and a variety of other substances.

In May 2017, the company announced that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation (Ambarii) had entered into a Letter-of-Intent (LOI) with Naturally Splendid Enterprises Ltd. (TSXV: NSP) for the production, sale and distribution of Ambarii’s proprietary sublingual full spectrum hemp CBD tablets in Japan and South Korea. Ambarii CBD Tablets offer a consistent, quick dissolving dose of full spectrum hemp oil, combined with the powerful antioxidant properties of pterostilbene.

Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The company focuses on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of super foods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC).

For more information, please visit www.lexariaenergy.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) Launches Its New and Expanded Interactive Website

June 29, 2017
  • LED lighting producer and leading indoor plant growth solutions provider
  • Focused on efficiencies for the legal cannabis industry
  • Website is now SEO-optimized, providing an easier way to order product

Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) has fully updated and SEO-optimized its e-commerce website (www.LEDCanada.com) in response to rising consumer demand for LED grow lights. The new and expanded site has gone live, and the LED product line can be viewed on LEDCanada.com.

The site now contains a number of social media buttons for Facebook, Twitter, and Pinterest. The LEDCanada.com website will be updated with the newest content from the company, such as blogs, client announcements, newsletters, and specific stories about client successes.

Based in Vancouver, the company is a Canadian LED manufacturer of residential and commercial lighting, fixtures, lamps, and more. It is also a leading indoor plant growth technology company specializing in LED lighting, mobile applications, and vertical farming solutions for the legal cannabis industry.

“Our goal with the updated website is to provide our customers with an easier way to order and learn about Future Farm’s LED grow light services and solutions by allowing them to browse information and order lights based on their own preferences,” William A. Gildea, chairman and chief executive officer of Future Farm, stated in a news release. “The website is now optimized for mobile devices, is interactive, and provides better access to information about LEDCanada.”

For more information, visit www.FutureFarmTech.com

Invictus MD (OTC: IVITF) (TSX.V: IMH): A Cannabis Company Living Up to its Name

June 27, 2017
  • Canadian Cannabis Valuations up 200% in two years
  • 250 acres of cultivation space stretching from Alberta to Ontario
  • Paid out $1,000,000 in Dividends representing $0.07 per Share

It might just be that Invictus MD Strategies Corp. (OTC: IVITF) (TSX.V: IMH) (FRA: 8IS) has adopted as a motto the elevating penultimate line from William Ernest Henley’s immortal poem Invictus: “I am the master of my fate”. Canada’s Cannabis Company appears completely unafraid as it ploughs ahead with its strategy to become a dominant company in Canada’s cannabis space. That boldness is paying off; Invictus is one of only a handful of cannabis companies declaring dividends. Now, with 250 acres of cultivation space stretching from Alberta to Ontario under management, Invictus is poised to deliver product to Canada’s medical and recreational marijuana markets, as Ottawa reiterates its determination to implement a legal framework for adult use by July 2018 (http://dtn.fm/yQG0j).

In executing that market domination strategy, Invictus’s management has pulled off some savvy deals since the company went public, under the symbol IMH, on the Canadian Securities Exchange (CSE) in December 2014. In March 2015, Invictus took up a 20 percent stake in hydroponic service company Future Harvest Development (FHD). Just four months later, it quickly increased that investment to acquire a majority holding and then sold off FHD’s Sunblaster Lighting division in February 2016. Those breathtaking developments provided a 216% return on investment; Sunblaster, sold for $2,850,000, had an acquisition cost of $900,000. Invictus now holds 82.5% of FHD.

Cannabis Health Sciences was another successful exit. The company, which publishes the Cannabis Health Journal, was bought for $45,000 and later sold for $230,000, earning Invictus a hefty return of 411 percent.

Invictus’ current portfolio companies have equal potential. Wholly-owned Acreage Farms of West-Central Alberta is currently valued at $34.5 million. The division received its cultivation license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on March 29, 2017, and is already operational. A 6,800 sq ft purpose built concrete and steel facility has already been constructed, and a planned expansion of 27,400 sq ft on the 150-acre property is imminent. Cultivation started in May 2017, and the unit is expected to reach output of 3,000 kg in 2018, 10,000 kg in 2019 and 25,000 kg by 2020.

In addition, together, associated companies AB Laboratories and AB Ventures are likely to do even better. Their joint production capacity is planned, by 2018, to hit 5,000 kg before climbing to 15,000 kg in 2019 and a level of 25,000 kg in 2020. AB Laboratories already has a cultivation license, received on October 21, 2016. The company, in which Invictus has a one-third stake, expects to get its sales license very soon and is currently valued at $30 million. Its facility in Hamilton, Ontario, covers about 16,000 sq ft.

AB Ventures is Invictus’s “startup” operation. The division closed a 100-acre acquisition in May 2017 and has filed an ACMPR pre-license application for that planned facility. It is aiming to develop 100,000 sq ft (about 2¼ acres) of cultivation and production space by 2019. The unit, in which Invictus also has a one-third stake, is valued at $22.5 million.

There is no doubt that halcyon days are ahead for Invictus. Valuations of cannabis companies have risen over 200 percent over the past two years, with some high fliers crossing the 300% mark. Valuations of ancillary businesses, those that supply services and equipment to the cannabis industry, are rising on the swell, too. Invictus was able to pay out a $1 million dividend to shareholders on December 5, 2016, representing $0.07 per share, because of its divestment of Sunblaster Lighting. With the Canadian recreational cannabis market projected to reach $6 billion, Invictus, now listed on the TSX-V under the symbol IMH, has a fate that looks decidedly promising.

For more information, please visit www.Invictus-MD.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Let QualityStocks Help You Navigate the Small Cap Market Terrain

June 16, 2017

Simply put, the small cap market is huge. Nearly 8 out of 10 companies that publicly trade in the United States have a market capitalization of less than $500 million. A surprising 40% of the businesses that trade on Nasdaq have a market capitalization of less than $250 million.

Yet these companies get very little if any analyst research coverage on Wall Street. You may have 52 analysts covering a $468 billion company like Apple, but practically no one covering the small cap company. The investment news media consisting of broadcasts media like CNBC or the magazines and financial newspapers also rarely mention small caps. As a result, the small cap’s stock price rarely reflects the company’s future prospects.

Yet small companies are the true leaders of innovation and creativity. Large companies are bureaucratic monstrosities. Think of the film Office Space where computer engineers stuck in cubicles feel their creativity is stifled while they are focused on pleasing middle management writing Testing Procedure Specification (TPS) reports. Large corporations have become totalitarian work environments where the CEOs are acting as dictators looking over Stalinesque bureaucracies and even their brightest staff members feel as if they are merely renting themselves to the company for a living. The large organizational hierarchies of big cap companies are slow in making decisions and require sticking to established stagnant procedures. Startups require innovative entrepreneurs, and that typically isn’t in a job description for a large company. An innovative entrepreneur would most likely be deemed a threat by corporate middle management.

Small cap companies are hampered by little if any bureaucracy and this leads to rapid decision making, fast adaptability to quick changing markets, and a willingness to take on the risk of new ideas. Large companies sometimes throw large amounts of money to innovate and get nowhere due to ineffective internal communication within their own departments. Clear communication among internal staff and a lack of funds triggers small companies to come up with different, unique, solutions to solve the problems that lead to innovations.

Small cap entrepreneurs are the visionary business people that do market research, create business plans, seek out investors and financing, and then strive to create products and services that utilize a country’s resources. They are the true job creators, and not the management of large corporations that seek to enhance profits by off-shoring labor or replacing people with automation. They are the value waiting to be unlocked in the small cap market.

Let QualityStocks become your portal to small cap investment success

QualityStocks can be your first step to researching small companies on the leading edge of entrepreneurial innovation.

For over 8 years, QualityStocks free daily newsletter has been providing quality investment ideas to small cap investors. QualityStocks delivers the only newsletter tracking the stock tips of hundreds of other investment newsletters, and providing a ‘One-Stop Look’ at the daily highlights of the small cap market. Once you begin subscribing to the QualityStocks daily newsletter, you will wonder how you ever managed without it.

For a free subscription, visit www.signup.qualitystocks.net

PV Nano Cell (PVNNF) Increases IP War Chest as Japanese Patent Office Grants Silver Nano Particles Patent for 3D Printing

June 15, 2017

A recent Forbes (http://dtn.fm/2WfWR) article shows just how far Additive Manufacturing (AM), a.k.a. 3D Printing, has come, reporting that the government of Dubai, United Arab Emirates, ‘has set a target for 25 percent of buildings to be 3D-printed by 2030.’ Apparently, the AM industry now believes it has the technology to “print” houses. That technological prowess also appears to extend to smaller objects, much smaller, where the challenges are different but just as formidable. An Economist feature (http://dtn.fm/71FDh) tells how a Chinese contract manufacturer is using 3D printers ‘to print electronic circuits, such as antennae and sensors, directly into products instead of making those components separately and assembling them into the devices.’ Printers need ink, however, and 3D printers need the special kind produced by PV Nano Cell (OTCQB: PVNNF). Under the Sicrys™ brand, the innovative Israeli outfit has developed a menu of customized single crystal nanometric conductive inks for use in the manufacture of a wide range of electronic devices.

The devices that PVNNF’s inks are designed to work with are less than Lilliputian. A nanometer is one-billionth of a meter or, put another way, it would take 25,400,000 nanometers in a line to cover a distance of just one inch. These tiny devices are, more often than not, required to transmit electrical signals and, consequently, need conductive inks of quality. Sicrys™ inks serve a wide range of applications that demand high-performance conductive inks, including mass produced printed electronics applications such as printed circuit boards, antennas, sensors, and touch screens, as well as photovoltaic applications, and are available in both silver-based and copper-based formulations.

PVNNF is bolstering its intellectual property (IP) war chest with a plethora of patents. In May 2017, the company announced (http://dtn.fm/xVPO4) that the Japanese Patent Office (JPO) had granted its silver nano particles patent. The company has already been granted patents in four countries for its silver single crystal nano particles based dispersions and inks and has submitted patents related to its silver and copper nano particles in nine other countries. To date, PVNNF has submitted patent applications for both its silver and copper nano particles in Brazil, China, Europe, India, Israel, Japan, Russia, South Korea, the United Kingdom and the U.S.

Owing to its general applicability, the Sicrys™ portfolio of conductive inks is appearing in many potentially lucrative market segments. For example, the market for “printing” antennas is about $0.5 billion, while for photovoltaic (PV) metallization it’s about $1.8 billion. For flexible and customized electronics, market size is estimated at around $2.0 billion, and for printed circuit boards (PCB) it is about $6.0 billion. The inks are already in use. Albuquerque, New Mexico-based Optomec prints antennas for the mobile industry using Sicrys™ inks, and Stratasys, a pioneer in developing 3D printing technologies, uses Sicrys™ too, as does inkjet technology provider Pixdro.

In the world of 3D printing, PV Nano Cell’s Sicrys™ ink family is hot off the press. The company continues its quest to develop the very best conductive inks for use in solar PV and printed electronics applications.

For more information, please visit www.PVNanoCell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

LottoGopher (CSE: LOTO) is Poised to Disrupt the Lottery Industry with Pioneering Online Service

These days, people want convenience. Consumers want things to be faster and easier, and they’re willing to pay for it. One company, LottoGopher Holdings Inc. (CSE: LOTO), is catering to that demand within the lottery realm.

The lottery industry is considered quite behind the times. Players must still buy their tickets in person, and many states require that lottery tickets be paid for with cash only. Because a paper ticket is all you get, it can also be easy to lose a lottery ticket, which contributes to approximately $2 billion in lottery winnings going unclaimed in United States every single year. LottoGopher, however, is poised to disrupt the lotto industry in a big way.

LottoGopher is a lottery messenger service that makes it possible for lotto players to order and manage their state lottery tickets online and to pay for them using debit and credit cards—no more need to leave home and stand in line to purchase lottery tickets. The service also makes it easier for players to keep track of their tickets and their winnings, stay current on the most recent drawings, and even collect winnings. LottoGopher members additionally have access to jackpot alerts, player strategies, lucky number pickers, lottery news and financial resources for winners.

Through LottoGopher, players can participate alone using a single ticket, or they can create and join public and private groups to pool winnings. Different LottoGopher memberships are available that let players order multiple tickets from different lotteries. To use the site, players can purchase a day pass, monthly passes or annual memberships, and ticket prices are not marked up for LottoGopher users. They pay the same price they would pay if buying a ticket in person.

At present, LottoGopher’s services are only available to residents of California, but the company plans to expand into 22 other lottery states. The company also has a goal of signing up 500,000 paying members within a four-year period. LottoGopher has already attracted a highly desirable strategic partner in Lottoland, which has 5.5 million customers across the globe and is a leading lottery betting company in Europe.

In 2014, Americans spent more than $70 billion on lottery tickets, making it a highly lucrative industry for a disruptive brand like LottoGopher. LottoGopher’s strategy involves targeting 80 million potential subscribers who already buy lottery tickets and have a history of online shopping.

LottoGopher began trading on the Canadian Securities Exchange in May 2017.

For more information about the company, visit www.LottoGopher.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Garbage to Gold: Itronics, Inc. (ITRO) Taps into Plentiful Silver Bullion Resource Using Pioneering Extraction Process

June 2, 2017

Diversified zinc fertilizer and silver producing green technology company Itronics (OTC: ITRO) recently announced it has commenced silver bullion production using e-scrap as a cost-reducing, precious metal-bearing raw material. E-scrap, which is ground-up computer circuit boards, is plentifully available and, therefore, offers a prime resource and an exceptional opportunity for the expansion of the company’s breakthrough recovery operation.

The bullion sales resulting from Itronics’ pioneering extraction process are anticipated to begin generating revenue for the company early in the third quarter of 2017. This new revenue stream will come online just as seasonal fertilizer sales start declining for the year.

Itronics is the creator and operator of a vertically integrated silver-bearing photoliquid recycling business that specializes in manufacturing specialty chelated liquid fertilizers, which are sold under the GOLD’n GRO brand, as well as pure silver bullion and silver-bearing glass. In essence, the company takes one of the most toxic liquid waste products produced in the United States and transforms virtually every bit of it into usable products. Sales of the environmentally beneficial GOLD’n GRO fertilizer are exceeding expectations, and this new revenue stream from silver bullion will bring yet another addition to Itronics’ revenues in the second half of 2017.

Using one of its large furnaces, the company has completed more than 20 test melts, which generated a portion of the silver bullion shipped by Itronics earlier this year and has since produce several hundred ounces more that have not yet been shipped. Because of the success of these test melts, Itronics has begun operating its second large melting furnace, as well. Both furnaces are currently in operation now, and the company is establishing an operating schedule for its bullion production, with current silver bullion production at an estimated 1,500 troy ounces per month.

The company continues to optimize its process and identify and implement potential furnace operation improvements on its way toward continual operation. Itronics tripled its “per melt” production between January and mid-April 2017, going from 500 ounces per month to 1,500. It is the company’s belief that further improvements in the coming several months could even further increase these “per melt” recoveries by as much as 50 percent. According to the Itronics bullion sales agreement, the time elapse from shipment to payment is about 60 days. Silver bullion shipped by the company during the second quarter of 2017 will be reported in Itronics’ third-quarter sales results.

It is anticipated that this new “zero waste” technology of using e-scrap as raw material will substantially increase both the profitability of Itronics’ silver recovery operation and the company’s revenues. Because of the cost-reducing attributes of this breakthrough recovery technology, Itronics’ silver bullion production segment may prove to be the stable, non-seasonal cash flow-generating revenue stream the company has been looking for. As the silver recovery operation grows, the addition of gold, palladium and copper will even further expand and stabilize revenues for Itronics.

For more information about the company, visit www.itronics.com.

UGE International Ltd. (UGEIF) Revenues Rocket 903% Higher as Solar Power Orders Surge

May 30, 2017

There are clear skies over the NYC headquarters of UGE International (OTCQB: UGEIF) (TSXV: UGE) as the energy solutions company continues to build its business organically and through acquisitions. UGE recently announced its first-quarter 2017 financial results, boasting record revenues of $5.5 million, up 903% over the prior year period. Now, the global provider of solar energy services is on track to take that top line even higher as its order book swells.

The solar power industry is driven by renewable portfolio standard (RPS) targets, state and federal tax credits, grants, and favorable public support for ‘green’ energy. A renewable portfolio standard (RPS), or renewable electricity standard, is a regulatory mandate to increase production of energy from renewable sources such as wind, solar, biomass and other alternatives to fossil and nuclear electric generation. The industry has experienced phenomenal growth over the past five years, achieving annual growth rate of approximately 76 percent from 2011 through 2016. A new report from GTM Research and SEIA (http://nnw.fm/bnLW5) indicates that rate could be trending even higher, revealing that the U.S. solar power market grew by 95 percent in 2016.

UGE is on the frontline of this industry as it powers its way into photovoltaic energy solutions; its recent financial results reflect that position. In the first quarter of 2017, UGE reported triple-digit growth in revenues (as noted above) and lowered its net loss to $0.4 million, compared to $1.7 million reported in the first quarter of 2016, marking the smallest loss in the last three years and bringing the company closer to profitability.

At March 31, 2017, the company also reported that its order backlog reached $31.6 million, of which $20.5 million were “confirmed” projects and $11.1 million of which were “contracted” projects.
“Our first quarter results further illustrate the progress we are making as a company to grow profitably in the commercial solar sector,” UGE CEO Nick Blitterswyk stated in the news release. “Our team continues to focus on growing and executing on our backlog, as our expectations for the future continue to grow as well.”

UGE provides services at all stages of the solar photovoltaic (PV) project lifecycle, including consulting and project management, engineering and design, turnkey construction, and development. The company has been engaged in a number of high-profile projects in the Northeast United States, Canada, Panama and the Philippines.

It was involved in the 84-panel installation that will provide 25.2 kW DC to the San Francisco campus of file-hosting company, Dropbox, and also undertook the utility scale ground mount installation at Sandringham and Woodville Solar Farms for Invenergy Clean Power of Ontario that will generate 25 MW (megawatts) of power. With a resume of over 130 commercial and industrial projects, UGE has already participated in installations with a capacity of over 280 MW.

With such a sunny prognosis, UGE’s share price has been on the rise, increasing by about 30 percent over the 12 months.

For more information, visit the company’s website at www.ugei.com

Conflicts of Interest and the Public Trust

May 24, 2017

Umpires and referees are hired to impartially officiate their respective games, enforce the rules and ensure fair play. The credence of these officials builds public trust and protects the integrity of the games. Everyone complains that the ump or the ref got the call wrong, but seldom, if ever, does anyone suspect a conflict of interest or believe these officials received payments from players, managers or owners of the teams. If these officials weren’t trustworthy, it would shake the confidence and probity of sports to its core. It would demoralize fans and destroy the games. Billions would be lost by everyone involved with sports. It’s imperative for the very life of the games that these officials maintain honesty and integrity and avoid even the appearance of conflicts of interest. Appearances matter.

If appearances do matter, why then are officials nominated and confirmed to officiate a $23 trillion game? Jay Clayton, a longtime partner at the law firm Sullivan & Cromwell, is the latest nominee to lead the Securities and Exchange Commission. Clayton follows many other SEC heads with multiple intertwined conflicts of interest that bring impartiality into question in regulating Wall Street. Clayton has represented big banks like Goldman Sachs and Barclays as well as prominent hedge funds, corporate executives and numerous companies facing intense government scrutiny. Clayton’s numerous conflicts of interest, intertwined investments and problematic clients were recently chronicled in the New York Times article, Trump’s S.E.C. Nominee Disclosure Offers Rare Glimpse of Clients and Conflicts (http://dtn.fm/t1eD7).

There is no doubt that Clayton is highly experienced and possesses an expansive understanding of market machinations. His knowledge and experience are necessary to rise to the task of running a complex government agency that regulates a complex business that utilizes complex instruments. From inception the SEC has had leadership conflicts of interest.

In 1934, Franklin Roosevelt appointed Joseph Kennedy to head the newly created Securities and Exchange Commission. FDR viewed the SEC as a part of the national recovery from the Great Depression and believed Kennedy was an ideal candidate to rein in all those other Wall Street charlatans. Through experience, Kennedy knew all the fraudulent, questionable backroom ways of lining the pockets of finance’s fat cats, and many believed the fox had been appointed chairman of the hen house. During his two years as SEC chairman, Kennedy stopped many dishonest activities and closed as many loopholes as he could, but his real mission was to make corporations feel good again about doing business. Corporations didn’t trust FDR and the New Deal, but Joe Kennedy was one of them.

Just maybe the game is rigged to promote business. The stated mission of the SEC is to protect investors; maintain fair, orderly, and efficient markets; and facilitate capital formation. The SEC also states that it strives to promote a market environment that is worthy of the public’s trust. With the current and historic appointments made to the SEC and the glaring history of conflicts of interest, it’s obvious that the SEC isn’t promoting an environment worthy of the public’s trust. The SEC is promoting an environment worthy of only the corporations’ trust.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BioCorRx, Inc. (BICX) Targeting Alcohol and Opioid Addiction with Innovative Two-Pronged Approach

BioCorRx (OTCQB: BICX) is the owner and creator of an innovative addiction treatment program used by a network of independent treatment centers to improve the lives of their patients struggling with alcohol and opioid addictions. The BioCorRx® Recovery Program leverages an innovative, two-pronged approach that addresses the underlying physical and behavioral issues associated with these addictions. The first half of this approach relies on a highly effective, proprietary implant formulation of the FDA-approved medication naltrexone, for which BioCorRx holds worldwide license rights (excluding Australia and New Zealand). The second half focuses on a modular counseling program coupled with overlapping peer support that is tailored specifically for those afflicted with alcohol and opioid addictions, helping to prepare them both physically and mentally for a life without these often dangerous substances.

America’s opioid epidemic is an increasingly treacherous issue that affects millions of people across the country. Per data from the Centers for Disease Control and Prevention, more than half a million people in the United States died from drug overdose from 2000 to 2015. Of those, more than 60 percent were linked to an opioid. Likewise, deaths from prescription opioids have more than quadrupled since 1999, driven by a nearly identical spike in the amount of prescription opioids sold. The negative implications associated with this addiction include traumatic life events for the addicted and their loved ones, as well as monumental financial expense. A 2010 study conducted by the American Society of Addiction Medicine found that addiction costs an estimated $700 billion annually in the U.S. alone.

Treating this growing problem has proven difficult. In 2011, the Substance Abuse and Mental Health Services Administration reported that 23.5 million persons aged 12 or older, roughly 9.3 percent of the population, needed treatment for an illicit drug or alcohol abuse problem. Of those, only 11.2 percent received the vital treatment at a specialty facility. BioCorRx aims to close this gap by both operating specialty facilities to aid those in need and providing a more thorough treatment program that’s been shown to lower patient drop-out rates, due to reduced cravings, and increase compliance rates, through automatic medication delivery and discreet outpatient treatment options.

In recent months, BioCorRx, through its BioCorRx Pharmaceuticals subsidiary, has looked to continue building on this proven medication through the clinical development of BICX101, a sustained release, injectable naltrexone for the treatment of opioid and alcohol use disorders. In early April, the company announced that three different formulations of the drug candidate showed success in reaching 28 days of sustained release in its preclinical studies, including one with an injection volume of just one milliliter. Following this result, BioCorRx formally requested a pre-IND meeting with the U.S. Food and Drug Administration as it continues to conduct additional studies in order to compile more data points.

In a business update issued earlier this month, Lourdes Felix, CFO, COO and director of BioCorRx, noted the strength of the company’s balance sheet following a March equity financing of $940,000 with accredited investors, as well as an investment of $1.7 million from Alpine Creek Capital Partners. Capital stemming from these transactions is expected to allow BioCorRx to continue executing on its business plan, including completion of “a few rounds of preclinical studies of BICX101” and accelerated sales and marketing activities related to its BioCorRx Recovery Program.

A strong balance sheet isn’t the only aspect of BioCorRx’s growth strategy about which prospective shareholders should be particularly optimistic. On May 16, the company announced its submission of a listing application for the Nasdaq Capital markets. The move comes less than two months after OTC Markets Group (OTCQX: OTCM) welcomed BioCorRx to the OTCQB Venture Market, which it reserves for early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process. The company will be required to meet a number of Nasdaq listing requirements in order to complete the uplist, but CFO Felix noted that members of BioCorRx’s management team “look forward to the prospect of a NASDAQ listing,” which they anticipate will “enhance BioCorRx’s visibility in the investment community to a larger market and provide for a broader, more diverse base of shareholders.”

Addressing the growing opioid epidemic in the United States, as well as lingering alcohol addiction issues, represents both an urgent call to action and a sizable market opportunity for companies offering proven effective treatment options. BioCorRx, through its innovative non-addictive medication-assisted treatment (MAT) program and promising clinical pipeline, represents an opportunity for the investment community to participate in the resolution of this crisis while capitalizing on the growth prospects of a leading edge health care solutions company.

For more information, visit www.BioCorRx.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Bitcoin Value Soars Despite SEC Rejecting ETF Bid, China Eyeing Trading Regulations

May 18, 2017

One of the most popular cryptocurrencies on the market, Bitcoin is reaching all-time highs on Asian trading platforms, despite recent challenges. The virtual currency has been rising in value, by 140 percent in 2016 and by roughly 50 percent in the past month alone, trading at over $1,800 on the Chinese market last week (http://dtn.fm/px7Ki). The value has dropped to around $1,700 in the meantime, but the cryptocurrency is expected to continue its growth, even if China is enforcing a series of Bitcoin trading regulations and Japan is considering the same.

One of the biggest challenges the digital currency is facing has to do with getting approval to be tied to an exchange-traded fund in the United States. Earlier this year, the U.S. Securities and Exchange Commission rejected a proposal to create a Bitcoin ETF on account of the lack of clear regulations on the markets where the cryptocurrency is traded (http://dtn.fm/EV7a8). The SEC said the lack of clear regulation on these markets raises concerns about potential manipulative or fraudulent practices in this market.

The application had been submitted by brothers Tyler and Cameron Winklevoss, who have been working on a proposed Bitcoin ETF for four years and have already won New York authorities’ regulatory approval for their virtual currency trading platform, Gemini Exchange. Other companies have also submitted approval request for Bitcoin ETFs to the SEC, and the commission may reach a different decision on those proposals, but approval is unlikely in the near future until more mature markets emerge.

Supporters of the digital currency had hoped that an ETF would help bring Bitcoin into the mainstream and make it available to retail investors via brokerage firms. The regulatory questions surrounding the currency have already deterred many financial institutions from investing significantly into Bitcoin, opting instead to focus on the underlying technology known as blockchain – a revolutionary concept that introduces a new way of processing financial transactions and keeping track of information.

Regulatory concerns over the cryptocurrency also exist on the Asian markets where Bitcoin is traded. China, responsible for almost 90 percent of all Bitcoin exchange trading, is imposing trading fees and controls, aimed at ensuring that bitcoin trading platforms are not becoming money laundering sites. A ban on cryptocurrency exchange withdrawals has also been enforced, and the country is also considering regulations that will require Bitcoin traders to register with their real names. The digital currency is being widely used by Chinese investors as a way of circumventing the country’s strict capital controls and minimizing the risk of significant losses caused by yuan deflation.

Japan, meanwhile, is taking rapid steps toward fully legitimizing the cryptocurrency, by announcing plans to allow interest-paying deposits for Bitcoin. The country has already declared Bitcoin a legal currency, establishing a platform for large corporations and institutional investors to participate in the local digital currency industry.

According to Sandeep Goenka, co-founder of one of India’s leading Bitcoin exchanges Zebpay, news of trading regulations on the two Asian markets and in Russia are partly what is driving the currency’s growth, Cointelegraph reports (http://dtn.fm/XO23d). Goenka believes that the stable growth rate is due to a global increase in awareness toward Bitcoin, as well as a growing demand from institutional investors. Instead of having a dampening effect, trading regulations will only help bring the cryptocurrency into the mainstream, says the Zebpay co-founder. In his opinion, the price of Bitcoin could reach $3,500 by the end of the year.

What the Future of SEC Enforcement Holds

May 16, 2017

The Dow Jones Industrial Average dropped 25 percent in the span of just four days during the stock market crash of 1929. The ‘29 crash was the worst in U.S. history, destroyed confidence in Wall Street and precipitated the Great Depression. The crash, the resultant financial malaise and shaken public confidence prompted calls for reform, and in 1934, the Securities and Exchange Commission (SEC) was created to restore public trust in capital markets and to oversee the conduct of those markets. Prior to the formation of the SEC, controls on issuing and trading of securities were virtually nonexistent, which allowed stock schemes and frauds to flourish. Rampant unrestricted margin trades and unreported concentrations of controlling interest led to abuses of power and market collapse. In total disregard of any ramifications, businesses, stock issuers and the exchanges essentially colluded and rigged markets to enrich themselves and their associates.

Attempting to restore order amid financial chaos, Congress passed legislation creating the Securities and Exchange Commission. The Securities Act of 1933 required public corporations to register their stock sales and make regular financial disclosures. The Securities Exchange Act of 1934 created the SEC to regulate exchanges, brokers, and over-the-counter markets, and the 1935 Public Utility Holding Company Act banned holding companies that obscured intertwined ownership.

The stated mission of the U.S. Securities and Exchange Commission is to protect investors, maintain fair, orderly, and efficient markets, and facilitate capital formation. Among its many duties, the SEC attempts to prevent market meltdowns by requiring transparency in financial instruments and by regulating stock issuers, brokerage firms and the major stock exchanges. It prohibits certain types of conduct, such as insider trading, and enforces laws that govern the financial industry. When necessary, the SEC enforces securities laws through a variety of means, including fines, referral for criminal prosecution, revocation or suspension of licenses, and injunctions. However, the SEC’s history of fair and equitable enforcement actions has often been called into question.

The Securities and Exchange Commission is a complex independent agency of the federal government which seeks to regulate complex financial instruments and markets. To chair or sit on the commission requires requisite skills and understanding of market complexities. Individuals typically tapped for appointment to the commission have extensive backgrounds, experience and relationships directly or tangentially related to the securities markets.

Herein is the rub… those that seek to regulate the markets and protect the public are cozied up with those that are often the bad actors requiring regulation. Much as during the financial crisis that promulgated the formation of the SEC, the largest market players operate with impunity and reap huge financial rewards. One need look no further than the lack of serious enforcement action (other than fines) after the mortgage shenanigans committed by large banks that led the financial crisis of 2007-2009. The SEC regulators were and still are from the same crowd that they purport to regulate and seem to always have multiple conflicts of interest.

What a conundrum. It requires experience and skill to effectively regulate the markets and its complexities, but those with the skill and experience to effectively regulate come from the very arena that needs oversight and carry luggage crafted from conflicts of interest.

The New York Times explores what the future of enforcement portends http://dtn.fm/40pqH under the latest nominee for chairman of the SEC and the conflicts of interest revealed by his financial disclosure form.

Financial Choice Bill Likely to Increase Insider Trading Risks for Small Investors

May 15, 2017

On May 4, 2017, after the House Financial Services Committee approved the Financial CHOICE Act of 2017 (FCA) in a 34-26 vote, Congress moved a step closer to replacing the Dodd-Frank Wall Street Reform and Consumer Protection Act. The bill will now be passed to the full House, proclaiming on the way its objective ‘to create hope and opportunity for investors, consumers and entrepreneurs by… holding Wall Street accountable’. However, many of its proposed changes appear to do the opposite. They hobble the SEC’s enforcement efforts: curtailing prosecutorial approaches and raising the bar for conviction by requiring stricter proof of wrongdoing. Even though other provisions increase the penalties for violations of securities laws, the FCA is likely to expose investors to increased market risk from fraudulent activity, including insider trading.

The scale of insider trading and the profits it promises are enormous. In 2014, for example, Mathew Martoma, a former portfolio manager at SAC Capital Advisors, was convicted for using confidential information to execute trades that yielded him $275 million, dubbed by former U.S. Attorney Preet Bharara, ‘as the “most lucrative” example of insider trading in history’ (http://dtn.fm/gZ5VK). Yet despite such staggering statistics, the FCA undermines the SEC’s ability to go after market manipulators like Martoma by including two provisions.

The first of these, which applies to the ‘standard of proof in administrative proceeding’, raises the bar by requiring the Commission to show ‘clear and convincing evidence’ that securities laws have been broken. This is a much more exacting standard than the ‘preponderance of the evidence’ standard required in federal courts and employed in SEC in-house hearings under existing rubric. Consequently, it is likely the SEC will decrease the number of cases pursued through administrative proceedings as it takes the path of least resistance.

Empowered by Frank-Dodd, in-house or administrative proceedings have proved to be a very effective enforcement tool for the SEC, so much so, that ‘according to a report (on May 9) by Cornerstone Research, the SEC filed 80 percent of its enforcement actions in the first half of fiscal year 2017 as administrative proceedings, not civil suits’, according to Reuters (http://dtn.fm/B1JQu).

The New York Times’ Deal Book explains (http://dtn.fm/RUn0O) this ‘attack on administrative proceedings’ as a ‘reaction to a provision of the Dodd-Frank Act that authorized the S.E.C. to pursue a wider range of penalties in cases filed with its own judges, which is usually a more expeditious procedure.’ The Deal Book story also questions ‘another provision (that) could allow defendants sued by the S.E.C. a means to challenge charges by claiming they had not been informed in advance of the theory of liability being pursued.’ The controversial provision referred to would ‘prohibit the S.E.C. from using “unproven legal theories” to establish a violation’, a clear sign that the FCA intends to keep insider training inside and not extend its penalties to outsiders.

Classic cases of insider trading occur when those who have obtained confidential information by reason of being a fiduciary of a corporation use that information to trade in the corporation’s securities. Such fiduciaries include directors and employees but also those who might temporarily become fiduciaries, such as attorneys, accountants, and consultants. However, in 1997, the Supreme Court, in United States v. O’Hagan, redefined insider trading. By ratifying the ‘misappropriation theory’, it cast a wider net of culpability when non-public information is used to trade securities.

O’Hagan was a partner in a law firm retained by a British company that planned to make a bid for the Pillsbury Company. Although, he was not assigned to work on that deal, O’Hagan learned about it over lunch. He, subsequently, began purchasing shares and options that netted him over $4 million in profits after the acquisition closed. Convicted at first instance of securities violations, the decision was reversed by an appellate court. On appeal by prosecutors, the Supreme Court held that an individual may be found liable for violating rule 10(b)-5, which forbids any fraud or deceit in connection with the purchase or sale of a security, by ‘misappropriating’ confidential information.

Now, any action to close the misappropriations route or make it more difficult for the SEC to take, might amount to declaring open season for insider trading.

At present, the law appears to allow an outsider to trade on confidential information, if the insider divulged the confidential information to the outsider because of friendship rather than for pecuniary gain, particularly if the outsider gave no undertaking that the information would not be used to trade. Indeed, in defending himself from ongoing SEC action, hedge fund billionaire Leon Cooperman is arguing ‘that even if he did get inside information, he did not agree to refuse to trade on it until after he’d already received it—and that therefore, the agreement was moot, from a legal standpoint’, according to Fortune magazine (http://dtn.fm/q2rA5). Cooperman, CEO of Omega Advisors, has been accused of making dozens of trades in Atlas Pipeline Partners securities in 2010, netting profits of $4 million, after learning from a company insider that the troubled oil and gas company was on the verge of a merger deal.

None of this bodes well for the financial markets. If Congress pursues its agenda of hamstringing the SEC, who will protect small investors?

BioCorRx (BICX) Offers New Hope for Individuals Addicted to Opioids, Alcohol

May 10, 2017

Addiction is a widespread crisis in the United States that doesn’t seem to have an end in sight. Both youth and adults suffer the devastating consequences of drug and alcohol addiction, and lives are lost and families are torn apart every day due to its destructive effects. In 2015 alone, more than 50,000 deaths resulted from drug overdoses in the U.S. (http://dtn.fm/2IdEz), but one company is offering new hope to millions of addicted individuals and their loved ones and making major strides to help turn the tide in America’s addiction epidemic.

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment company engaged in developing and providing cutting-edge solutions to treat alcohol and opioid addictions. The company has pioneered a fresh approach to addiction treatment, offering a non-addictive, medication-assisted treatment (MAT) program that consists of two main parts: an outpatient implant procedure performed by a licensed physician and a specially tailored one-on-one counseling program.

The first component of the BioCorRx Recovery Program involves the insertion of an implant that delivers naltrexone to addiction patients. Naltrexone is a non-addictive opioid antagonist that is able to significantly reduce an individual’s physical cravings for opioids and alcohol. The presence of the implant and its ongoing delivery of naltrexone make part two of the BioCorRx Recovery Program possible: one-on-one counseling that is specifically designed to treat the substance abuse addictions of patients receiving long-term naltrexone treatment. Because their addiction cravings have been quelled by the naltrexone, patients are able to make greater progress in psychosocial treatment and can more effectively address the underlying issues driving their addictive behaviors. The result is a much greater chance for patients to achieve long-term sobriety.

BioCorRx CEO Brady Granier recently discussed this revolutionary new treatment program on FOX News (http://dtn.fm/aWB4K) and FOX Business (http://dtn.fm/jZg1Z), detailing the BioCorRx program and the success it is having among patients. Granier also discussed an injectable naltrexone option the company currently has in preclinical development. Through BioCorRx Pharmaceuticals, an R&D subsidiary of BioCorRx, the company is developing, in partnership with TheraKine LTD, a new injection delivery technology for naltrexone called BICX101. This injectable naltrexone offers an additional naltrexone delivery option for addicted individuals in treatment.

BioCorRx also recently announced it has entered into an agreement with DynamiCare Health, Inc. to develop a co-branded mobile application, called DynamiCare Rewards™, with BioCorRx CBT that supports patients who are in treatment for addiction. This app will provide patients with a self-guided, interactive version of the BioCorRx Recovery Program and will enable counselors to remotely monitor their patients’ progress as patients complete the 35 modules of the program.

The tremendous success of BioCorRx’s twofold addiction treatment program—addressing both the physical and psychological aspects of opioid and alcohol addiction—is offering fresh hope for addicted individuals and their loved ones throughout the country.

For more information, visit the company’s website at www.BioCorRx.com

Whistleblowers Finger Bad Actors in the Financial Markets and Get Paid Millions by the SEC for Doing So

Back in 1970, in a seminal paper titled The Market for Lemons, George Akerlof highlighted how vitally important accurate information was to the effective functioning of the financial markets. It stands to reason: if the information reported by firms cannot be trusted, few would want to invest. The obfuscation and fraud practiced at Enron, WorldCom and other entities in the 1990s and disguised under a façade of positive earnings reports provided devastating proof, however, that the markets had not developed effective mechanisms for tackling information asymmetry, which occurs when one party to a contract knows a great deal more than the other. The recent financial crisis provided further evidence. The triple-A credit ratings assigned by agencies such as Moody’s and Standard & Poor’s turned out to be ‘fake news’. In response, Congress passed the Dodd–Frank Act, which as part of its mandate to reform Wall Street and protect consumers instituted the Office of the Whistleblower under the aegis of the U.S. Securities and Exchange Commission.

Akerlof, in his insightful magnum opus, analyzed the role of information by examining the market for used cars, which has ‘peaches’ (good cars) and ‘lemons’ (bad ones). Since buyers are acutely aware that sellers of lemons are likely to pass off their cars as peaches, they lower their bids on all cars. This, however, drives many owners of good cars to take their peaches off the market. Naturally, those selling bad cars are unperturbed by the fall in prices and are quite happy to continue offering their lemons. The average quality of cars offered, consequently, falls, since there are less peaches but the same number of lemons. This initiates a vicious cycle, with buyers further lowering their bids and more peaches leaving the market. Akerlof’s insight was to show that informational asymmetry diminishes transactions in any marketplace by driving out quality. He went on to marry Janet Yellen, the present Chair of the Federal Reserve, in 1978 and to win the Nobel Prize in Economics for his work in 2001.

Despite the lament in a recent New York Times article (http://dtn.fm/bo07E) on the SEC’s apparent deafness when an employee at giant mortgage insurer Radiant Group complained his employer was materially understating estimates of claims liability, the Whistleblower program appears to have had some measure of success. In its 2016 Annual Report to Congress, the SEC announced that since its inception on August 12, 2011, the Whistleblower program had ‘awarded more than $111 million to 34 whistleblowers’, with one award in 2014 being worth a whopping $30 million. That’s an awful lot of money for blowing a whistle, and, although the program was designed to provide insiders with incentives to report bad behavior by their employers, the size of the payouts is beginning to attract the attention of outsiders as well.

The Gulf News (http://dtn.fm/aUn1G) tells how two vigilant analysts stand to win as much as $2.5 million after tipping off the SEC about discrepancies in the earnings reports of Texas-based medical device maker Orthofix International NV. Their million-dollar award will come out of the $8.25 million the errant company has to pay. They are not the only ones. In January 2016, the SEC paid ‘more than $700,000 to a company outsider who conducted a detailed analysis that led to a successful SEC enforcement action’. The agency has said that ‘just over a third of the more than $111 million awarded to whistle-blowers went to outsiders such as analysts or short-sellers’. Those numbers have increased. At May 2, 2016, approximately $154 million had been awarded to 44 whistleblowers.

The law requires whistleblower awards to be a minimum of 10 percent of monetary sanctions collected; however, they can go up to a maximum of 30 percent. With its Whistleblower program, the SEC is encouraging investors to do their due diligence and get paid for it. Hopefully, this will encourage market participants to keep their operations as clean as a whistle.

Navidea Biopharmaceuticals (NYSE: NAVB) Precision Immunodiagnostics, a Game Changer for Patients and Physicians

May 9, 2017

Precision medicine and precision diagnostics in particular play a major role in today’s medical world, by helping patients and physicians detect various diseases in time, which in turn allows for the proper treatments and care to be prescribed. Companies such as Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) are at the forefront of precision medicine, developing innovative immunodiagnostics and immunotherapeutic platforms that can make a real difference for patients suffering from serious ailments such as cancer or infectious, autoimmune or inflammatory diseases.

A leader in precision medicine via the development and commercialization of precision diagnostics and therapeutics based on immune system functions, Ohio-based biopharma company Navidea is working on multiple products built around its proprietary Manocept™ platform. The platform is based on the ability to target macrophages – a type of white cells essential to immune systems, whose main role is to detect microscopic foreign bodies or substances and eat them, for the detection, monitoring and treatment of specific diseases. Manocept™ is able to specifically target the CD206 mannose receptor present in targeted macrophages, allowing for enhanced flexibility and versatility and, ultimately, leading to increased diagnostic accuracy and improved targeted treatment and patient care.

The platform is at the core of Navidea’s flagship product, Lymphoseek®, a state-of-the-art, receptor-targeted radiopharmaceutical agent used for the mapping of lymphatic basis or the biopsy of sentinel lymph nodes in patients with different types of cancers. Administered as an injection of technetium Tc 99m tilmanocept, Lymphoseek® has been successfully used for diagnostics in patients with clinically node negative breast cancer, squamous cell carcinoma of the oral cavity or melanoma.

Lymphoseek® has been approved by the U.S. Food and Drug Administration and has been in use nationwide since its launch in 2013. Recently, Navidea sold American rights to the diagnostic tool to Cardinal Health Inc. (NYSE: CAH) for a guaranteed $100 million in payments over the next three years (http://dtn.fm/32PpG). The sale’s value could rise to $310 million throughout the life of the agreement. In addition, Navidea already has European distribution in place for the cancer diagnostic aid and is seeking further commercialization opportunities in the rest of the world.

Aside from Lymphoseek®, the company is looking for other ways to expand the use of its Manocept™ platform, for diagnostics across a wide range of disorders such as rheumatoid arthritis, Crohn’s disease, tuberculosis, Kaposi’s sarcoma and others. Navidea is already looking into expanding the targeted macrophages-based platform diagnostic for many of these disorders, with clinical studies underway for rheumatoid arthritis, cardiovascular disease and more.

Another potential use for the Manocept™ platform is the development of macrophage therapeutics using the Lymphoseek® delivery system. The company is currently working on the development of immunotherapeutics for cancer, inflammatory, autoimmune and infectious diseases and has so far reported encouraging results in preclinical trials, data suggesting several positive drug properties in terms of safety, duration of action, deliverability and costs. Results of animal testing have also indicated clear progress of macrophage therapeutics for various disorders including arthritis, asthma, Nonalcoholic Steatohepatitis-related inflammation, neuro-inflammation and multiple cancers.

For more information about Navidea Biopharmaceuticals and its innovative precision immunodiagnostic tools, visit the company’s website at www.Navidea.com

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Set to Increase Revenues Substantially in 2017 with New Acquisition

May 8, 2017

The hiatus after its initial public offering (IPO) in 2014 has come to an end, and Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) has rebooted its acquisition strategy by bringing two new businesses under its wing. In late 2016, the company completed its acquisition of MediGain, LLC, a Texas-based medical billing specialist, and its subsidiary, Millennium Practice Management Associates, LLC, a New Jersey-based medical billing company. Now, with its bottom line enhanced as costs are spread over the larger organizational structure, MTBC is also set to see its top line improve substantially.

The MediGain acquisition will expand MTBC’s revenue base significantly, adding approximately 200 customers and $10 million in annualized revenues. As a result, for the first quarter of 2017, with an earnings report due on Wednesday, May 10, revenues are expected to rise by approximately 60% year-over-year to $8.2 million with “significantly improved” net loss and adjusted EBITDA. Overall revenue growth of over 20 percent is forecast for 2017, up from 2016 revenues of $24.5 million, and the top line is expected to hit $30 million.

The MediGain acquisition is a real feather in MTBC’s cap, bringing a number of advantages to the company. For starters, the purchase price of $7 million for $10 million worth of revenue represents a 30% discount on the industry norm multiple of 1x. As Warren Buffet famously said, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

Net present value of the acquisition is positive, as the discounted cash flows from the acquisitions exceed MTBC’s cost of capital, already noted by the market and reflected by a rise in the share price, and MTBC has gained talented team members in North America and expanded its Asia-based team to additional countries with talented, cost-effective workforces.

With these acquisitions, MTBC continues its focus on smaller one- to 10-doctor practices. The company provides software-as-a-service (SaaS) solutions to assist health care providers generate invoices, prepare and mail statements to their patients and submit insurance claims. It also provides electronic health record (EHR) software that allows providers to record notes of a visit and practice management software for the front office staff to schedule appointments, check insurance eligibility, send out automated reminder calls and text messages about flu shots, etc.

In addition to these services, practitioners and patients have access to a suite of mobile applications, including apps that the doctors can use to refill prescriptions and apps that the patients can use to look up their records, set up appointments, request prescription refills and check in when they arrive at the practice. Doctors who do not want to type their notes into the EHR can dictate into an app on their iPhone or Android device, which will be sent automatically to MTBC personnel, who will listen to it and type the notes into the electronic health record software.

MTBC’s main competitive advantage is its ability to deliver these services at a cost far less than any competitor. This is partly because MTBC has bought or established a number of overseas subsidiaries, sourcing expertise and talent for much less than is obtainable in the U.S. MTBC’s two largest offices are in Pakistan, where it employs 1,500 people at salaries of approximately one-tenth what you would pay in the United States for similarly skilled and educated labor.

For more information, visit www.MTBC.com

Code Green Apparel Corp. (CGAC) Puts Green in Your Bank, Green on Your Back

April 27, 2017

Environmentally friendly practices are becoming more and more important for industries that are trailed by long traditions of waste. Bringing fresh green practices to the apparel industry, Code Green Apparel Corp. (OTC: CGAC) is working to reduce the environmental impact of this industry by reclaiming textile waste that has heretofore rotted in landfills. Instead, this pre-consumer waste is now being recycled and reused in the making of new garments, with countless mounds and pounds of textile waste being diverted from the landfill and used in the creation of uniforms and other apparel products.

Code Green Apparel’s recycling technology accomplishes multiple enviro-friendly aims. In reclaiming cotton from those huge mounds of textile waste, the company is not only reducing and reusing waste but is simultaneously saving massive amounts of water. While cotton is one of the most desirable textiles on earth, it is also one of the thirstiest crops, and it can take thousands of gallons of water to grow the amount of cotton needed to make just one shirt or pair of pants. By recycling the cotton from textile waste, Code Green Apparel is saving huge amounts of water that would have otherwise been consumed in growing fresh cotton crops. Not only is Code Green Apparel recycling cotton from massive amounts of textile waste, but the company is imbuing polyester and other fabric blends with new life as well.

Once Code Green Apparel returns textile waste to its original form, it is handled in the same way as any other textile at a typical garment manufacturing facility. What’s more, the apparel products created from this recycled material have the same look, feel, and performance quality of a non-recycled clothing item. In weaving yarns and sewing fabrics, the company adheres to the same industry standards as any other apparel manufacturer. The difference is, of course, that environmental harm is significantly reduced thanks to Code Green Apparel’s green and sustainable practices.

There is also one other notable difference: Code Green Apparel’s uniforms and products are less expensive than non-recycled apparel items. The company’s factory direct business model lets businesses purchase uniforms for their employees at a lower cost than would be incurred if purchasing non-recycled apparel. The environment wins, and so do American businesses!

For more information about Code Green Apparel, its practices and products, visit www.CodeGreenApparelCorp.com

How Quest Resource Holding Corp. (NASDAQ: QRHC) Plans to Use Business Waste to Fuel Triple-Digit, Top-Line Growth

Humans are a wasteful bunch, and our habits in the business world are no different. While a minimal amount of waste in the workplace is recycled, Texas-based Quest Resource Holdings (NASDAQ: QRHC) believes the nation’s corporations can do a lot better. As a provider of sustainability, recycling and environmental services, Quest is focused on strengthening its own top line while helping large corporations reduce their operating cost and minimize their eco-footprint.

Through its Quest Resource Management Group and Early911 subsidiaries, Quest designs and manages sustainability, recycling and resource management programs for the automotive, grocery/restaurant, industrial, property management and sustainability industries. With more than 38,000 client locations across the country, Quest has managed more than 1.37 million tons of waste, including used motor oil, trash, organics, used tires and card board.

In January 2017, Quest expanded its reach into the construction and demolition (C&D) industry, which spent $1.18 billion in 2016 alone – marking the industry’s highest level of spending in a decade. According to the Department of Commerce, the increase correlates with rising demand for project services and waste management as construction companies seek to minimize risk and cost, increase insight and control, and address environmental goals of clients.

For Quest, this means opportunity. Quest leverages its national footprint and cloud-based service and reporting platform to provide clients the ability to control cost, access waste disposal alternatives, streamline logistics, and increase efficiencies. Using the C&D industry as an example of this strategy, Quest’s construction-centered offerings include general requirement services such as temporary offices, storage containers, toilets and hand washing stations, holding tanks, water tanks and dumpsters. C&D waste and recycling services include solutions for materials such as wood, concrete, roofing, drywall, metal, plastic and blast media recycling, as well as hazardous and non-hazardous waste.

These solutions are executed through a time-saving, streamlined process in which Quest handles incoming requests, schedules and manages services, and provides LEED® credit tracking and sustainability reporting, enabling busy construction managers to focus on building their projects.

To facilitate its own growth, Quest operates an organic and acquisition-based strategy that creates a base of recurring revenues generated through fees for waste and recycling services, the sale of recyclable material in the commodity market, professional services, and the sale of operational products such as waste collection containers, compacting equipment and fleet maintenance products.

In 2016, backed with a credit facility with up to $20 million in borrowing capacity, the company refined its go-to-market strategy to optimize its market opportunities and reinforce the foundation for growth. The plan enabled the expansion of existing markets, entry into new industry verticals, and wins from new and existing customers.

These initiatives enabled the company to drive fourth-quarter revenues to $45.0 million, a year-over-year increase of 2%. Full-year 2016 revenues of $184 million represent an increase of 8% from total revenues in 2015. In the fourth quarter of 2016 the company also improved its gross margin by 50 basis points to 8.2%, and narrowed its net loss to $1.3 million compared to $2.8 million for the comparable quarter of 2015.

Pivoting off this growth, the company has its sight set on a market opportunity valued at $55 billion, with anticipation for continued momentum.

“We expect improved performance in 2017, reflecting our refocused go-to-market strategy and our efforts to enhance the value add of our services portfolio. Those initiatives, including our focused approach to customer acquisition, are expected to result in 1% to 2% improvement in gross margin and positive Adjusted EBITDA by the end of 2017,” S. Ray Hatch, president and CEO of Quest, stated in the earnings release. “Long term, we expect our strategy will return the company to double-digit top-line growth. In addition, we plan to show continued growth during the next several years and have established a three-to-five-year gross margin target in the low to mid-teens and an Adjusted EBITDA margin target of 4% to 6%.”

For more information visit www.qrhc.com

OTC Markets Group Announces Proposed Changes to OTCQB Standards; Comment Period Underway

April 20, 2017

OTC Markets Group has announced the publication of proposed amendments to the OTCQB Standards, which are scheduled to go into effect May 18, 2017.

Among these proposed changes, OTC Markets Group proposes the addition of new eligibility criteria for companies not required to be SEC reporting. OTC Markets Group further purposes the refining of various continued eligibility requirements and the reorganization of several sections for improved clarity.

Companies following the Alternative Reporting Standard may now become qualified for the OTCQB and will be required to make public disclosure available through the OTC Disclosure & News Service in accordance with the OTCQX and OTCQB Disclosure Guidelines, which are the same disclosure guidelines used by OTCQX companies. In addition, these Alternate Reporting Companies will have certain corporate governance requirements.

Other proposed changes relate to the timing for removing delinquent filers, revision of due dates for International Reporting filings, annual certification of good standing in the state or jurisdiction of incorporation, and the procedures for removing a company from OTCQB for bid price deficiency.

A comment period is ongoing through May 17, and those with feedback regarding the proposed changes should send their comments and questions to mike@otcmarkets.com.

The proposed rules can be read in their entirety at http://dtn.fm/4EywP

RenovaCare, Inc. (RCAR) Leading Innovation in Wound Care Treatment

April 13, 2017

The global wound care market recently reached revenues of more than $20 billion (http://dtn.fm/W1wjB) at the end of 2016, based on sales at the manufacturer’s level. Specifically, the burn care market is expected to grow at a CAGR of 6.8% from $1.68 billion in 2016 to more than $2.33 billion by the end of 2021 (http://dtn.fm/I6abR). The growth in these markets has been largely attributed to factors such as the rising number of burn accidents, an aging population, and the rise in cardiovascular diseases, diabetes, obesity, and other diseases that can cause skin-related problems.

Currently, wound care ranges from anti-infectives, ulcer wound management, moist dressings, and negative pressure wound therapy to wound closure and even conventional skin grafts. These treatments can be extremely painful, slow-to-heal, and are more likely to face complications along the way. Today, more is being done to help patients suffering from skin problems, some of which include a rise in health care expenditure, more government initiatives, an increase in the number of emergency centers and burn units, and a growing understanding of the various treatment options.

In addition, more innovative forms of treatment are slowly being introduced. RenovaCare, Inc. (OTCQB: RCAR), a development stage biotechnology company focused on acquiring, researching, developing, and commercializing first-of-their-kind self-donated stem cell therapies for the regeneration of human organs, is in the process of developing a product that targets issues relating to the human body’s largest organ, the skin.

The company’s CellMist™ system uses a patient’s own stem cells and is applied onto wounds and burns using its SkinGun™. The technology is able to regrow the skin across wounds by spreading numerous regenerative islands over the affected area, rather than the wound healing from the outside in. Although still part of an experimental setting, the system has been tested on patients such as Matt Uram, a victim of a fire-related accident during a July fourth celebration, who, within three days witnessed incredible results, with burns almost completely healed and no risk of infection or scarring (http://dtn.fm/uXAR5).

RenovaCare believes the SkinGun™ could replace today’s standards of care, decreasing the need for patients to go through the process of having complicated skin grafts, mesh skin grafts, and other forms of painful treatment.

The company is aiming to get the SkinGun™ FDA-approved in the near future, and research is already underway at RenovaCare to enable the treatment of third degree burns, which are more complex in nature and often come with damage to the muscles and tissue below the skin.

For more information, visit www.RenovaCareInc.com

Marina Biotech, Inc. (MRNA) Sets Further Development of Drug Candidates IT-102 and IT-103, Signs Windlas Healthcare Manufacturing Agreement

April 7, 2017

Marina Biotech Inc. (OTCQB: MRNA) filed a 10K with the SEC on April 5, 2017, for its year ended December 31, 2016. The late stage biopharmaceutical company summarized its achievements in 2016 and provided an outlook into its 2017 performance, including its planned clinical trials in 2018. Marina Biotech specializes in creating and commercializing innovative therapies for treatments of cancer, hypertension, and arthritis.

The firm plans to move by the first quarter of 2018 into a phase 3 clinical study of its drug candidate, IT-102, a fixed dose combination (FDC) bi-layer tablet, said Joseph Ramelli, chief executive officer of Marina Biotech. It recently signed an agreement for Windlas Healthcare Limited to manufacture the tablet, positioning Marina Biotech for the Phase 3 study. That India-based firm has facilities that are approved by the Food & Drug Administration (FDA) in the U.S., as well as the European Union Good Manufacturing Practices (EU cGMP).

The company also reported:

  • Marina Biotech expanded its unsecured credit line from its chairman, Dr. Vuong Trieu, on April 4, 2017, for an additional $500,000. The initial line was for $540,000 secured last November. The company had drawn down $250,000 of that by December 31, 2016. The company also secured another line of credit from Autotelic, Inc., for the commercialization of IT-102 and IT-103.
  • The company announced that it has completed its merger with IThena Pharma, enabling it to advance its development of combination tablets for arthritis, pain, cancer and hypertension. The transaction with IThena Pharma has put in motion a new pipeline by Marina Biotech that advances its development of combination therapies.
  • Marina Biotech announced the results of new preclinical and clinical data for its drug candidates IT-102 and IT-103. These results support the further development of both for the treatment of hypertension/pain, Ramelli said. Among these results was the indication that IT-102 and IT-103 could serve as unique anticancer agents.
  • In February of 2017 the company entered into a licensing agreement with LipoMedics, under which Marina Biotech could receive up to $90 million in milestone payments which are success based. Under that agreement, Marina Biotech gave a license to LipoMedics for its SMARTICLES platform for the delivery of nanoparticles, including small molecules.

For more information, visit www.MarinaBio.com

Archives

Select A Month
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search

    Categories

    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • Algae Dynamics Corp. ADYNF (9)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • Alltemp, Inc. LTMP (1)
  • AlphaTrade.com APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • Barchart.com (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • BizRocket.com Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • BlastGard International Inc. BLGA (5)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • Bollente Companies, Inc. BOLC (2)
  • BoonMarket.com (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises, Inc. CDII (48)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • Chineseinvestors.com, Inc. CIIX (38)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • Connect-A-Jet.com CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Converde Energy USA Inc. XFUL (12)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (73)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • EFoodSafety.com Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz, Inc. EPAZ (28)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Etelcharge.com Inc. ETLC (3)
  • Ethema Health Corporation GRST (7)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (81)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  • Fund.com, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • GotStocks.net (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • Greenstone Holdings Inc. GSHN (2)
  • GREM USA GRMU (2)
  • Grey Cloak Tech, Inc. GRCK (5)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital, Inc. IGC (21)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • InMed Pharmaceuticals, Inc. IMLFF (16)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kootenay Zinc Corp. KTNNF (12)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lexaria Bioscience Corp. LXRP (5)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Loans4Less.com Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • MGX Minerals, Inc. MGXMF (4)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (48)
  • Money4Gold Holdings Inc. MFGD (3)
  • MortgageBrokers.com Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • MyStaru.com Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (24)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One Step Vending Corp. KOSK (2)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,353)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORHub, Inc. ORHB (16)
  • OTCPicks.com (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot One Technologies, Inc. PTOTF (12)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Players Network PNTV (15)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProBility Media Corp. PBYA (22)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,171)
  • QualityStocks Video Charts (286)
  • QualityStocks.net Market Basics (6)
  • QualityStocksNewsBreaks (79)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (88)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • Smallcaps.us (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (3)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,895)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune, Inc. TPIV (15)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.